Resistance to a Nucleoside Analog Antiviral Drug from More Rapid Extension of Drug-Containing Primers

Nucleoside analogs are mainstays of antiviral therapy. Although resistance to these drugs hinders their use, understanding resistance can illuminate mechanisms of the drugs and their targets. Certain nucleoside analogs, such as ganciclovir (GCV), a leading therapy for human cytomegalovirus (HCMV), c...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Han, Lawler, Jessica L., Filman, David J., Hogle, James M., Coen, Donald M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7885103/
https://www.ncbi.nlm.nih.gov/pubmed/33563814
http://dx.doi.org/10.1128/mBio.03492-20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7885103/
https://www.ncbi.nlm.nih.gov/pubmed/33563814
http://dx.doi.org/10.1128/mBio.03492-20

Ejemplares similares